Screener
Globus Medical GMED Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Payments related to tax withholdings for share-based compensation | (3,453) | (2,953) |
| Repurchase of common stock | (136,058) | (215,451) |
| Repayment of senior convertible notes | — | (449,985) |
| Net cash provided by/(used in) financing activities | (116,299) | (660,333) |
| Effect of foreign exchange rates on cash | (2,495) | 17,899 |
| Net increase/(decrease) in cash and cash equivalents | (18,411) | (554,992) |
| Cash and cash equivalents at beginning of period | 526,156 | 784,438 |
| Cash and cash equivalents at end of period | $507,745 | $229,446 |
Item 1. Financial Statements
FAQ
- What is Globus Medical's financing cash flow?
- Globus Medical (GMED) reported financing cash flow of -$134.5M in Q2 2026.
- How has Globus Medical's financing cash flow changed year-over-year?
- Globus Medical's financing cash flow decreased by 439.3% year-over-year, from -$24.94M to -$134.5M.
- What is the long-term trend for Globus Medical's financing cash flow?
- Over 2 years (2021 to 2025), Globus Medical's financing cash flow has grown at a 254.3% compound annual growth rate (CAGR), from $55.17M to -$692.38M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Globus Medical's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude